GO:0061034 | olfactory bulb mitral cell layer development | 8.19e-04 | 1.00e+00 | 10.253 | 1 | 1 | 1 |
GO:0090230 | regulation of centromere complex assembly | 8.19e-04 | 1.00e+00 | 10.253 | 1 | 1 | 1 |
GO:0004998 | transferrin receptor activity | 8.19e-04 | 1.00e+00 | 10.253 | 1 | 1 | 1 |
GO:0004632 | phosphopantothenate--cysteine ligase activity | 8.19e-04 | 1.00e+00 | 10.253 | 1 | 1 | 1 |
GO:0031134 | sister chromatid biorientation | 8.19e-04 | 1.00e+00 | 10.253 | 1 | 1 | 1 |
GO:0097286 | iron ion import | 8.19e-04 | 1.00e+00 | 10.253 | 1 | 1 | 1 |
GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity | 8.19e-04 | 1.00e+00 | 10.253 | 1 | 1 | 1 |
GO:0019521 | D-gluconate metabolic process | 8.19e-04 | 1.00e+00 | 10.253 | 1 | 1 | 1 |
GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity | 8.19e-04 | 1.00e+00 | 10.253 | 1 | 1 | 1 |
GO:0045252 | oxoglutarate dehydrogenase complex | 1.64e-03 | 1.00e+00 | 9.253 | 1 | 1 | 2 |
GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity | 1.64e-03 | 1.00e+00 | 9.253 | 1 | 1 | 2 |
GO:0034088 | maintenance of mitotic sister chromatid cohesion | 1.64e-03 | 1.00e+00 | 9.253 | 1 | 1 | 2 |
GO:0019322 | pentose biosynthetic process | 1.64e-03 | 1.00e+00 | 9.253 | 1 | 1 | 2 |
GO:0007070 | negative regulation of transcription from RNA polymerase II promoter during mitosis | 1.64e-03 | 1.00e+00 | 9.253 | 1 | 1 | 2 |
GO:0016605 | PML body | 1.75e-03 | 1.00e+00 | 4.950 | 2 | 4 | 79 |
GO:0072562 | blood microparticle | 1.84e-03 | 1.00e+00 | 4.914 | 2 | 2 | 81 |
GO:0006104 | succinyl-CoA metabolic process | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 3 |
GO:0009051 | pentose-phosphate shunt, oxidative branch | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 3 |
GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 3 |
GO:2000001 | regulation of DNA damage checkpoint | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 3 |
GO:0071459 | protein localization to chromosome, centromeric region | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 3 |
GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 3 |
GO:0030976 | thiamine pyrophosphate binding | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 3 |
GO:0006457 | protein folding | 2.63e-03 | 1.00e+00 | 4.653 | 2 | 4 | 97 |
GO:0071922 | regulation of cohesin localization to chromatin | 3.27e-03 | 1.00e+00 | 8.253 | 1 | 1 | 4 |
GO:0043550 | regulation of lipid kinase activity | 3.27e-03 | 1.00e+00 | 8.253 | 1 | 1 | 4 |
GO:0035189 | Rb-E2F complex | 3.27e-03 | 1.00e+00 | 8.253 | 1 | 1 | 4 |
GO:0034349 | glial cell apoptotic process | 3.27e-03 | 1.00e+00 | 8.253 | 1 | 1 | 4 |
GO:0021860 | pyramidal neuron development | 3.27e-03 | 1.00e+00 | 8.253 | 1 | 1 | 4 |
GO:0006554 | lysine catabolic process | 3.27e-03 | 1.00e+00 | 8.253 | 1 | 1 | 4 |
GO:0009108 | coenzyme biosynthetic process | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 5 |
GO:0021695 | cerebellar cortex development | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 5 |
GO:0048667 | cell morphogenesis involved in neuron differentiation | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 5 |
GO:0030957 | Tat protein binding | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 2 | 5 |
GO:0045842 | positive regulation of mitotic metaphase/anaphase transition | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 5 |
GO:0000730 | DNA recombinase assembly | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 3 | 5 |
GO:0006734 | NADH metabolic process | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 5 |
GO:0000082 | G1/S transition of mitotic cell cycle | 4.33e-03 | 1.00e+00 | 4.288 | 2 | 24 | 125 |
GO:0043353 | enucleate erythrocyte differentiation | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 6 |
GO:0000075 | cell cycle checkpoint | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 2 | 6 |
GO:0070688 | MLL5-L complex | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 6 |
GO:0016018 | cyclosporin A binding | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 6 |
GO:0031625 | ubiquitin protein ligase binding | 5.25e-03 | 1.00e+00 | 4.145 | 2 | 5 | 138 |
GO:0005662 | DNA replication factor A complex | 6.54e-03 | 1.00e+00 | 7.253 | 1 | 3 | 8 |
GO:0021756 | striatum development | 6.54e-03 | 1.00e+00 | 7.253 | 1 | 1 | 8 |
GO:0006098 | pentose-phosphate shunt | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 9 |
GO:0097284 | hepatocyte apoptotic process | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 9 |
GO:0010569 | regulation of double-strand break repair via homologous recombination | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 2 | 9 |
GO:0015939 | pantothenate metabolic process | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 9 |
GO:0031571 | mitotic G1 DNA damage checkpoint | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 2 | 9 |
GO:0015937 | coenzyme A biosynthetic process | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 9 |
GO:0050998 | nitric-oxide synthase binding | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 10 |
GO:0045780 | positive regulation of bone resorption | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 10 |
GO:0021794 | thalamus development | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 10 |
GO:0042551 | neuron maturation | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 10 |
GO:0045651 | positive regulation of macrophage differentiation | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 10 |
GO:0006103 | 2-oxoglutarate metabolic process | 8.98e-03 | 1.00e+00 | 6.794 | 1 | 1 | 11 |
GO:0035267 | NuA4 histone acetyltransferase complex | 9.79e-03 | 1.00e+00 | 6.668 | 1 | 3 | 12 |
GO:0051146 | striated muscle cell differentiation | 9.79e-03 | 1.00e+00 | 6.668 | 1 | 1 | 12 |
GO:0045445 | myoblast differentiation | 1.06e-02 | 1.00e+00 | 6.553 | 1 | 2 | 13 |
GO:0016514 | SWI/SNF complex | 1.06e-02 | 1.00e+00 | 6.553 | 1 | 1 | 13 |
GO:0035861 | site of double-strand break | 1.06e-02 | 1.00e+00 | 6.553 | 1 | 1 | 13 |
GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 15 |
GO:0045879 | negative regulation of smoothened signaling pathway | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 15 |
GO:0030863 | cortical cytoskeleton | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 15 |
GO:0045070 | positive regulation of viral genome replication | 1.30e-02 | 1.00e+00 | 6.253 | 1 | 1 | 16 |
GO:0006298 | mismatch repair | 1.38e-02 | 1.00e+00 | 6.166 | 1 | 4 | 17 |
GO:0000718 | nucleotide-excision repair, DNA damage removal | 1.38e-02 | 1.00e+00 | 6.166 | 1 | 5 | 17 |
GO:0033572 | transferrin transport | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 18 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 5 | 18 |
GO:0030316 | osteoclast differentiation | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 18 |
GO:0048565 | digestive tract development | 1.55e-02 | 1.00e+00 | 6.005 | 1 | 1 | 19 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.55e-02 | 1.00e+00 | 6.005 | 1 | 1 | 19 |
GO:0043044 | ATP-dependent chromatin remodeling | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 2 | 20 |
GO:0006099 | tricarboxylic acid cycle | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 20 |
GO:0032201 | telomere maintenance via semi-conservative replication | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 7 | 20 |
GO:0007346 | regulation of mitotic cell cycle | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 2 | 21 |
GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 2 | 21 |
GO:0019894 | kinesin binding | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 1 | 21 |
GO:0001895 | retina homeostasis | 1.79e-02 | 1.00e+00 | 5.794 | 1 | 1 | 22 |
GO:0051084 | 'de novo' posttranslational protein folding | 1.79e-02 | 1.00e+00 | 5.794 | 1 | 2 | 22 |
GO:0000722 | telomere maintenance via recombination | 1.79e-02 | 1.00e+00 | 5.794 | 1 | 7 | 22 |
GO:0000413 | protein peptidyl-prolyl isomerization | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 1 | 24 |
GO:0003755 | peptidyl-prolyl cis-trans isomerase activity | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 1 | 24 |
GO:0006096 | glycolytic process | 2.03e-02 | 1.00e+00 | 5.610 | 1 | 2 | 25 |
GO:0007093 | mitotic cell cycle checkpoint | 2.03e-02 | 1.00e+00 | 5.610 | 1 | 1 | 25 |
GO:0031492 | nucleosomal DNA binding | 2.03e-02 | 1.00e+00 | 5.610 | 1 | 2 | 25 |
GO:0051219 | phosphoprotein binding | 2.03e-02 | 1.00e+00 | 5.610 | 1 | 2 | 25 |
GO:0050661 | NADP binding | 2.11e-02 | 1.00e+00 | 5.553 | 1 | 1 | 26 |
GO:0006091 | generation of precursor metabolites and energy | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 1 | 27 |
GO:0034332 | adherens junction organization | 2.27e-02 | 1.00e+00 | 5.446 | 1 | 1 | 28 |
GO:0031072 | heat shock protein binding | 2.27e-02 | 1.00e+00 | 5.446 | 1 | 2 | 28 |
GO:0006271 | DNA strand elongation involved in DNA replication | 2.35e-02 | 1.00e+00 | 5.395 | 1 | 8 | 29 |
GO:0000781 | chromosome, telomeric region | 2.35e-02 | 1.00e+00 | 5.395 | 1 | 2 | 29 |
GO:0070527 | platelet aggregation | 2.35e-02 | 1.00e+00 | 5.395 | 1 | 1 | 29 |
GO:0051402 | neuron apoptotic process | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 2 | 30 |
GO:0050681 | androgen receptor binding | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 2 | 30 |
GO:0021766 | hippocampus development | 2.51e-02 | 1.00e+00 | 5.299 | 1 | 2 | 31 |
GO:0001102 | RNA polymerase II activating transcription factor binding | 2.51e-02 | 1.00e+00 | 5.299 | 1 | 2 | 31 |
GO:0000278 | mitotic cell cycle | 2.54e-02 | 1.00e+00 | 2.959 | 2 | 35 | 314 |
GO:0044281 | small molecule metabolic process | 2.59e-02 | 1.00e+00 | 2.117 | 3 | 32 | 844 |
GO:0006284 | base-excision repair | 2.59e-02 | 1.00e+00 | 5.253 | 1 | 8 | 32 |
GO:0019900 | kinase binding | 2.59e-02 | 1.00e+00 | 5.253 | 1 | 1 | 32 |
GO:0035914 | skeletal muscle cell differentiation | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 1 | 33 |
GO:0021762 | substantia nigra development | 2.75e-02 | 1.00e+00 | 5.166 | 1 | 1 | 34 |
GO:0030521 | androgen receptor signaling pathway | 2.83e-02 | 1.00e+00 | 5.124 | 1 | 2 | 35 |
GO:0031966 | mitochondrial membrane | 2.83e-02 | 1.00e+00 | 5.124 | 1 | 1 | 35 |
GO:0005654 | nucleoplasm | 2.86e-02 | 1.00e+00 | 2.064 | 3 | 55 | 876 |
GO:0005905 | coated pit | 2.99e-02 | 1.00e+00 | 5.044 | 1 | 2 | 37 |
GO:0070062 | extracellular vesicular exosome | 3.15e-02 | 1.00e+00 | 1.573 | 4 | 43 | 1641 |
GO:0050680 | negative regulation of epithelial cell proliferation | 3.15e-02 | 1.00e+00 | 4.968 | 1 | 1 | 39 |
GO:0042802 | identical protein binding | 3.17e-02 | 1.00e+00 | 2.786 | 2 | 7 | 354 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 3.23e-02 | 1.00e+00 | 4.931 | 1 | 6 | 40 |
GO:0006879 | cellular iron ion homeostasis | 3.23e-02 | 1.00e+00 | 4.931 | 1 | 1 | 40 |
GO:0003684 | damaged DNA binding | 3.31e-02 | 1.00e+00 | 4.896 | 1 | 9 | 41 |
GO:0001047 | core promoter binding | 3.39e-02 | 1.00e+00 | 4.861 | 1 | 2 | 42 |
GO:0000724 | double-strand break repair via homologous recombination | 3.39e-02 | 1.00e+00 | 4.861 | 1 | 5 | 42 |
GO:0055037 | recycling endosome | 3.47e-02 | 1.00e+00 | 4.827 | 1 | 1 | 43 |
GO:0045216 | cell-cell junction organization | 3.55e-02 | 1.00e+00 | 4.794 | 1 | 1 | 44 |
GO:0051087 | chaperone binding | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 3 | 45 |
GO:0003725 | double-stranded RNA binding | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 3 | 45 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 2 | 45 |
GO:0019903 | protein phosphatase binding | 3.79e-02 | 1.00e+00 | 4.699 | 1 | 3 | 47 |
GO:0000723 | telomere maintenance | 3.79e-02 | 1.00e+00 | 4.699 | 1 | 8 | 47 |
GO:0001558 | regulation of cell growth | 3.95e-02 | 1.00e+00 | 4.639 | 1 | 2 | 49 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 3.95e-02 | 1.00e+00 | 4.639 | 1 | 3 | 49 |
GO:0006767 | water-soluble vitamin metabolic process | 4.03e-02 | 1.00e+00 | 4.610 | 1 | 2 | 50 |
GO:0006469 | negative regulation of protein kinase activity | 4.03e-02 | 1.00e+00 | 4.610 | 1 | 1 | 50 |
GO:0006898 | receptor-mediated endocytosis | 4.18e-02 | 1.00e+00 | 4.553 | 1 | 1 | 52 |
GO:0006302 | double-strand break repair | 4.18e-02 | 1.00e+00 | 4.553 | 1 | 8 | 52 |
GO:0006289 | nucleotide-excision repair | 4.26e-02 | 1.00e+00 | 4.525 | 1 | 9 | 53 |
GO:0034329 | cell junction assembly | 4.26e-02 | 1.00e+00 | 4.525 | 1 | 1 | 53 |
GO:0006766 | vitamin metabolic process | 4.26e-02 | 1.00e+00 | 4.525 | 1 | 2 | 53 |
GO:0006338 | chromatin remodeling | 4.42e-02 | 1.00e+00 | 4.472 | 1 | 2 | 55 |
GO:0031175 | neuron projection development | 4.42e-02 | 1.00e+00 | 4.472 | 1 | 1 | 55 |
GO:0016032 | viral process | 4.50e-02 | 1.00e+00 | 2.512 | 2 | 32 | 428 |
GO:0003697 | single-stranded DNA binding | 4.58e-02 | 1.00e+00 | 4.421 | 1 | 6 | 57 |
GO:0000785 | chromatin | 4.73e-02 | 1.00e+00 | 4.371 | 1 | 5 | 59 |
GO:0007265 | Ras protein signal transduction | 4.73e-02 | 1.00e+00 | 4.371 | 1 | 3 | 59 |
GO:0071013 | catalytic step 2 spliceosome | 4.89e-02 | 1.00e+00 | 4.323 | 1 | 5 | 61 |
GO:0016023 | cytoplasmic membrane-bounded vesicle | 5.05e-02 | 1.00e+00 | 4.276 | 1 | 1 | 63 |
GO:0042470 | melanosome | 5.13e-02 | 1.00e+00 | 4.253 | 1 | 2 | 64 |
GO:0047485 | protein N-terminus binding | 5.20e-02 | 1.00e+00 | 4.231 | 1 | 2 | 65 |
GO:0005200 | structural constituent of cytoskeleton | 5.44e-02 | 1.00e+00 | 4.166 | 1 | 2 | 68 |
GO:0006928 | cellular component movement | 5.59e-02 | 1.00e+00 | 4.124 | 1 | 1 | 70 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 5.59e-02 | 1.00e+00 | 4.124 | 1 | 1 | 70 |
GO:0006325 | chromatin organization | 5.59e-02 | 1.00e+00 | 4.124 | 1 | 3 | 70 |
GO:0014069 | postsynaptic density | 5.83e-02 | 1.00e+00 | 4.064 | 1 | 1 | 73 |
GO:0044237 | cellular metabolic process | 5.98e-02 | 1.00e+00 | 4.025 | 1 | 1 | 75 |
GO:0042127 | regulation of cell proliferation | 6.37e-02 | 1.00e+00 | 3.931 | 1 | 3 | 80 |
GO:0005819 | spindle | 6.37e-02 | 1.00e+00 | 3.931 | 1 | 4 | 80 |
GO:0030529 | ribonucleoprotein complex | 6.53e-02 | 1.00e+00 | 3.896 | 1 | 4 | 82 |
GO:0031982 | vesicle | 6.91e-02 | 1.00e+00 | 3.810 | 1 | 1 | 87 |
GO:0061024 | membrane organization | 7.07e-02 | 1.00e+00 | 3.778 | 1 | 2 | 89 |
GO:0007050 | cell cycle arrest | 7.30e-02 | 1.00e+00 | 3.730 | 1 | 3 | 92 |
GO:0006260 | DNA replication | 7.45e-02 | 1.00e+00 | 3.699 | 1 | 11 | 94 |
GO:0005768 | endosome | 7.75e-02 | 1.00e+00 | 3.639 | 1 | 1 | 98 |
GO:0034641 | cellular nitrogen compound metabolic process | 8.29e-02 | 1.00e+00 | 3.539 | 1 | 18 | 105 |
GO:0000790 | nuclear chromatin | 8.59e-02 | 1.00e+00 | 3.485 | 1 | 3 | 109 |
GO:0005615 | extracellular space | 9.51e-02 | 1.00e+00 | 1.907 | 2 | 8 | 651 |
GO:0030424 | axon | 1.00e-01 | 1.00e+00 | 3.253 | 1 | 2 | 128 |
GO:0000398 | mRNA splicing, via spliceosome | 1.00e-01 | 1.00e+00 | 3.253 | 1 | 8 | 128 |
GO:0009897 | external side of plasma membrane | 1.02e-01 | 1.00e+00 | 3.220 | 1 | 1 | 131 |
GO:0005759 | mitochondrial matrix | 1.08e-01 | 1.00e+00 | 3.134 | 1 | 5 | 139 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 1.11e-01 | 1.00e+00 | 3.104 | 1 | 2 | 142 |
GO:0044822 | poly(A) RNA binding | 1.35e-01 | 1.00e+00 | 1.611 | 2 | 25 | 799 |
GO:0000166 | nucleotide binding | 1.35e-01 | 1.00e+00 | 2.794 | 1 | 6 | 176 |
GO:0003713 | transcription coactivator activity | 1.41e-01 | 1.00e+00 | 2.730 | 1 | 5 | 184 |
GO:0005975 | carbohydrate metabolic process | 1.43e-01 | 1.00e+00 | 2.714 | 1 | 2 | 186 |
GO:0005856 | cytoskeleton | 1.46e-01 | 1.00e+00 | 2.684 | 1 | 2 | 190 |
GO:0006281 | DNA repair | 1.55e-01 | 1.00e+00 | 2.588 | 1 | 19 | 203 |
GO:0008134 | transcription factor binding | 1.59e-01 | 1.00e+00 | 2.546 | 1 | 4 | 209 |
GO:0043234 | protein complex | 1.60e-01 | 1.00e+00 | 2.539 | 1 | 8 | 210 |
GO:0019899 | enzyme binding | 1.60e-01 | 1.00e+00 | 2.539 | 1 | 4 | 210 |
GO:0043231 | intracellular membrane-bounded organelle | 1.65e-01 | 1.00e+00 | 2.485 | 1 | 7 | 218 |
GO:0005829 | cytosol | 1.67e-01 | 1.00e+00 | 1.035 | 3 | 58 | 1787 |
GO:0019901 | protein kinase binding | 1.75e-01 | 1.00e+00 | 2.395 | 1 | 11 | 232 |
GO:0007411 | axon guidance | 1.79e-01 | 1.00e+00 | 2.365 | 1 | 1 | 237 |
GO:0003723 | RNA binding | 1.85e-01 | 1.00e+00 | 2.305 | 1 | 11 | 247 |
GO:0005925 | focal adhesion | 2.09e-01 | 1.00e+00 | 2.114 | 1 | 4 | 282 |
GO:0005515 | protein binding | 2.10e-01 | 1.00e+00 | 0.566 | 5 | 76 | 4124 |
GO:0009986 | cell surface | 2.15e-01 | 1.00e+00 | 2.069 | 1 | 2 | 291 |
GO:0055114 | oxidation-reduction process | 2.26e-01 | 1.00e+00 | 1.987 | 1 | 3 | 308 |
GO:0045892 | negative regulation of transcription, DNA-templated | 2.32e-01 | 1.00e+00 | 1.945 | 1 | 7 | 317 |
GO:0055085 | transmembrane transport | 2.40e-01 | 1.00e+00 | 1.891 | 1 | 1 | 329 |
GO:0007596 | blood coagulation | 2.46e-01 | 1.00e+00 | 1.848 | 1 | 4 | 339 |
GO:0048471 | perinuclear region of cytoplasm | 2.49e-01 | 1.00e+00 | 1.827 | 1 | 5 | 344 |
GO:0044267 | cellular protein metabolic process | 2.55e-01 | 1.00e+00 | 1.794 | 1 | 5 | 352 |
GO:0005634 | nucleus | 2.57e-01 | 1.00e+00 | 0.589 | 4 | 67 | 3246 |
GO:0016020 | membrane | 2.59e-01 | 1.00e+00 | 1.016 | 2 | 38 | 1207 |
GO:0045893 | positive regulation of transcription, DNA-templated | 2.70e-01 | 1.00e+00 | 1.695 | 1 | 10 | 377 |
GO:0045087 | innate immune response | 3.16e-01 | 1.00e+00 | 1.433 | 1 | 7 | 452 |
GO:0005887 | integral component of plasma membrane | 3.85e-01 | 1.00e+00 | 1.086 | 1 | 2 | 575 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 3.88e-01 | 1.00e+00 | 1.069 | 1 | 6 | 582 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 4.21e-01 | 1.00e+00 | 0.922 | 1 | 8 | 644 |
GO:0005739 | mitochondrion | 4.28e-01 | 1.00e+00 | 0.889 | 1 | 11 | 659 |
GO:0005576 | extracellular region | 4.30e-01 | 1.00e+00 | 0.881 | 1 | 5 | 663 |
GO:0006355 | regulation of transcription, DNA-templated | 4.56e-01 | 1.00e+00 | 0.772 | 1 | 7 | 715 |
GO:0005524 | ATP binding | 5.35e-01 | 1.00e+00 | 0.453 | 1 | 23 | 892 |
GO:0046872 | metal ion binding | 5.53e-01 | 1.00e+00 | 0.386 | 1 | 10 | 934 |
GO:0003677 | DNA binding | 5.58e-01 | 1.00e+00 | 0.366 | 1 | 18 | 947 |
GO:0006351 | transcription, DNA-templated | 6.07e-01 | 1.00e+00 | 0.182 | 1 | 9 | 1076 |
GO:0005730 | nucleolus | 6.55e-01 | 1.00e+00 | 0.004 | 1 | 41 | 1217 |
GO:0005886 | plasma membrane | 8.01e-01 | 1.00e+00 | -0.547 | 1 | 11 | 1784 |
GO:0005737 | cytoplasm | 9.19e-01 | 1.00e+00 | -1.109 | 1 | 50 | 2633 |